targeted anticancer therapy
Dasatinib
Treats a cancer by targeting tumour cells. This molecule appears in 225 of the medicines we have indexed.
Do you need a supplement? No.
No supplement is warranted with this treatment. A varied diet remains the foundation.
Do you also take another treatment?
By the Layer Nutrition editorial teamHow the atlas classifies the 664 molecules
- Class
- targeted anticancer therapy kinase inhibitor
- Indexed medicines
- 225
- Our answer
- Nothing to add
- Updated
- October 2026
What this medicine is for
Pharmacologically, this molecule belongs to the “targeted anticancer therapy (kinase inhibitor)” category. This targeted therapy attacks a specific mechanism of tumor cells; it falls under a specialized hospital prescription.
In practice: Treats a cancer by targeting tumor cells. It is part of specialised, closely monitored care.
The name on your box may be here.
These names come from the public registers of 32 countries: the ANSM for France, the AEMPS for Spain, the AIFA for Italy, the HPRA for Ireland, Swissmedic for Switzerland, and the European Medicines Agency for the others.
Most widespread
- DARUPH
- MUBUCHO
- NODRIGA
- ДАЗАТИНИБ ТЕВА
- DASA-ABZ
- DASATILEN
- DAZATINIB SANDOZ
- SPECENIB
- UXIL
- SPRYCEL
No name matches.
See all names, country by countryHide the list by country
France8
- SPRYCEL
- DASATINIB BIOGARAN
- DASATINIB EG
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ZENTIVA
Germany12
- DARUPH
- DASA-ABZ
- DASATILEN
- SPRYCEL
- DASATINIB 1 A PHARMA
- DASATINIB AL
- DASATINIB HEUMANN
- DASATINIB RATIOPHARM
- DASATINIB VIATRIS
- DASATINIB VIVANTA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Spain8
- DARUPH
- SPRYCEL
- DASATINIB ACCORD HEALTHCARE
- DASATINIB COMBIX
- DASATINIB EUGIA
- DASATINIB STADA
- DASATINIB TEVA
- DASATINIB VIATRIS
Italy9
- DARUPH
- SPRYCEL
- DASATINIB ACCORD HEALTHCARE
- DASATINIB AUROBINDO
- DASATINIB EG
- DASATINIB KRKA
- DASATINIB MYLAN
- DASATINIB SANDOZ
- DASATINIB ZENTIVA
United Kingdom10
- UXIL
- DASATINIB ACCORD
- DASATINIB GENERICS UK
- DASATINIB MYLAN
- DASATINIB SANDOZ
- DASATINIB STADA
- DASATINIB TEVA
- DASATINIB TILLOMED
- DASATINIB TILLOMED LABORATORIES
- DASATINIB ZENTIVA
Ireland6
- MUBUCHO
- SPRYCEL
- DASATINIB ACCORD HEALTHCARE
- DASATINIB CLONMEL
- DASATINIB KRKA
- DASATINIB TEVA
Switzerland6
- SPRYCEL
- DASATINIB ACCORD
- DASATINIB SANDOZ
- DASATINIB SPIRIG HC
- DASATINIB-TEVA
- DASATINIB ZENTIVA
Austria4
- DARUPH
- SPRYCEL
- DASATINIB G.L.
- DASATINIB ACCORD HEALTHCARE
Belgium6
- SPRYCEL
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ACCORD HEALTHCARE
Bulgaria4
- ДАЗАТИНИБ ТЕВА
- SPRYCEL
- DASATINIB SANDOZ
- DASATINIB ACCORD HEALTHCARE
Cyprus4
- SPECENIB
- SPRYCEL
- DASATINIB TEVA
- DASATINIB ACCORD HEALTHCARE
Croatia7
- NODRIGA
- SPRYCEL
- DASATINIB ALPHA-MEDICAL
- DASATINIB STADA
- DASATINIB TEVA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Denmark10
- SPRYCEL
- DASATINIB KRKA
- DASATINIB "SANDOZ"
- DASATINIB STADA
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB VIVANTA
- DASATINIB VIVANTA GENERICS
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Estonia5
- SPRYCEL
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Finland7
- SPRYCEL
- DASATINIB AVANSOR
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB STADA
- DASATINIB VIATRIS
- DASATINIB ACCORD HEALTHCARE
Greece4
- SPRYCEL
- DASATINIB FARAN
- DASATINIB TEVA
- DASATINIB ACCORD HEALTHCARE
Hungary10
- DARUPH
- DAZATINIB SANDOZ
- SPRYCEL
- DASATINIB KRKA
- DASATINIB MYLAN
- DASATINIB ONKOGEN
- DASATINIB SANDOZ
- DASATINIB STADA
- DASATINIB TEVA
- DASATINIB ACCORD HEALTHCARE
Iceland5
- SPRYCEL
- DASATINIB ACCORD HEALTHCARE
- DASATINIB KRKA
- DASATINIB MYLAN
- DASATINIB STADA
Latvia5
- SPRYCEL
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Liechtenstein3
- SPRYCEL
- DASATINIB ACCORD
- DASATINIB ACCORD HEALTHCARE
Lithuania6
- SPRYCEL
- DASATINIB KRKA
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Luxembourg4
- SPRYCEL
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ACCORD HEALTHCARE
Malta4
- SPRYCEL
- DASATINIB CLONMEL
- DASATINIB SYNTHON
- DASATINIB ACCORD HEALTHCARE
Norway8
- SPRYCEL
- DASATINIB ACCORD HEALTHCARE
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB TEVA
- DASATINIB TEVA B.V.
- DASATINIB TEVA PHARMA
- DASATINIB VIATRIS
Netherlands10
- SPRYCEL
- DASATINIB CF
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB SYNTHON
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB VIVANTA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Poland9
- DARUPH
- SPRYCEL
- DASATINIB EUGIA
- DASATINIB SANDOZ
- DASATINIB STADA
- DASATINIB SUN
- DASATINIB VIATRIS
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Portugal10
- MUBUCHO
- SPRYCEL
- DASATINIB EUGIA
- DASATINIB GENERIS
- DASATINIB KRKA
- DASATINIB MYLAN
- DASATINIB SANDOZ
- DASATINIB TEVA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Romania10
- NODRIGA
- SPRYCEL
- DASATINIB KRKA
- DASATINIB MSN
- DASATINIB SANDOZ
- DASATINIB STADA
- DASATINIB SUN
- DASATINIB TEVA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Slovakia8
- DARUPH
- SPRYCEL
- DASATINIB KRKA
- DASATINIB MSN
- DASATINIB SANDOZ
- DASATINIB TEVA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Slovenia5
- NODRIGA
- SPRYCEL
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB ACCORD HEALTHCARE
Sweden11
- DARUPH
- MUBUCHO
- SPRYCEL
- DASATINIB
- DASATINIB AVANSOR
- DASATINIB KRKA
- DASATINIB SANDOZ
- DASATINIB STADA
- DASATINIB TEVA
- DASATINIB ZENTIVA
- DASATINIB ACCORD HEALTHCARE
Czechia7
- DARUPH
- SPRYCEL
- DASATINIB MSN
- DASATINIB SANDOZ
- DASATINIB TEVA
- DASATINIB VIATRIS
- DASATINIB ACCORD HEALTHCARE
One answer out of three.
The atlas gives each molecule one of these three answers. Most call for nothing.
- Our formula31 molecules
- An active ingredient to consider59 molecules
- Nothing to add574 moleculesincluding this one
In the same family
Do you also take another treatment?
Type the name written on the box. The atlas gives you its answer.
For example Panadol, Doliprane or paracetamol.